Research by the World Health Organization (WHO) states that around
17 million deaths have been noticed annually due to strokes. The higher
mortality rate associated with strokes showcases an impending need for new and
innovative drugs and diagnostic devices. As per the latest report released by
Market Research Future (MRFR), the Global Ischemic Stroke Market Trends is
expected to attain a CAGR of approximately 7.8% during the forecast period
between 2023 and 2032.
Ischemic Strokes occur when an artery or blood vessel supplying
blood to the brain is blocked. The brain is dependent on the arteries to bring
fresh blood from the lungs and heart. A blockage in the same causes ischemic
stroke. The underlying reason behind such obstruction is the development of
fatty deposits lining the vessel walls, also known as atherosclerosis.
The evolving lifestyle of individuals, prevalence of diabetes,
increasing ageing population, and high tobacco usage are the major factors
driving the market. Additionally, the increasing demand for minimally invasive
procedures and advancements in surgical procedures are some of the key factors
accelerating the growth of the global market. However, the high cost associated
with such surgical procedures and the excessive medicinal usage for the
treatment of the condition is reported as a major hindrance to the market
growth.
Competitive Landscape
The Global Ischemic
Stroke Market Report players includes numerous
prominent players like Stryker Corporation (U.S.), Johnson & Johnson
(U.S.), Abbott Laboratories (U.S.), Genentech, Inc. (U.S.), Merck & Co.,
Inc. (U.S.), Sanofi (France), Bayer AG (Germany), Koninklijke Philips N.V.
(Netherland), Boston Scientific Corporation (U.S.), Medtronic plc (U.S.),
Siemens Healthcare (U.S.), Pfizer Inc. (U.S.), GE Healthcare (U.S.), Covidien
PLC (Ireland), GE Healthcare (U.S.), Philips Healthcare (U.S.), Hitachi,
Ltd (Japan), Boehringer Ingelheim (Germany), Penumbra, Inc. (U.S.), Cordis
Corporation (U.S.), Daiichi Sankyo (U.S.), Biogen (U.S.), and others.
Market Segmentation
The Global Ischemic Stroke Market Outlook segmentation is based on
key dynamics like drug class, diagnosis, end-users, and surgery.
·
By drug class, the
market segments into anticoagulant, tissue plasminogen activator,
antihypertensive, antiplatelet, and others.
·
By diagnosis, the
market includes carotid ultrasound Computed Tomography (CT), echocardiography,
cerebral angiography, Magnetic resonance imaging (MRI), electrocardiography,
and others.
·
By end-user, the
market comprises of medical institutes, research organizations, hospitals &
clinics, and others.
·
By surgery, the market divides into
endovascular mechanical thrombectomy, carotid endarterectomy, and angioplasty.
Regional Analysis
The Global Ischemic
Stroke Market Overview is geographically segmented into the following
regions: Asia Pacific, America, Europe, and the Middle East and Africa.
The Americas is reported to be the largest market for ischemic
stroke due to technological innovations, favorable government initiatives, and
rising demand for ischemic stroke products.
Europe holds the second largest share of the market and is
expected to hold on to the same in the forthcoming years due to numerous
factors. Rising prevalence of acute ischemia stroke cases and advancements in
the surgical device technology are two key factors driving the market herein.
Other driving factors of the market in this region is the growing number of
diabetes mellitus population primarily in the developed nations of
Europe.
Asia Pacific is identified to witness the most promising growth in
the forecast period to cement its place in the global ischemic stroke market.
The proliferating growth of the region can be attributed to the widespread
prevalence of stroke cases in the Asia Pacific region. Both China and India are
two of the major contributors to the regional market and will play major roles
in accelerating the overall Asia Pacific region. Manufacturers are quickly
realizing the potential this region holds and are expanding their operations
therein to capitalize on the same.
The Middle East region is anticipated to grow at a fast rate owing
to factors like increasing emphasis on research and development activities in
the healthcare sector and continuous development of the healthcare
infrastructure.
Market
Research Future (MRFR) enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact
us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99
Hudson Street,5Th Floor, New York,
New
York 10013
